✦ LIBER ✦

Ten-year results of a randomised trial comparing cisplatin with cisplatin and cyclophosphamide in advanced, suboptimally debulked ovarian cancer

✍ Scribed by C Marth; C Tropé; I.B Vergote; G.B Kristensen

Book ID: 117664232
Publisher: Elsevier Science
Year: 1998
Tongue: English
Weight: 127 KB
Volume: 34
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(97)10171-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term results of a randomized trial

Long-term results of a randomized trial comparing cisplatin with cisplatin and cyclophosphamide with cisplatin, cyclophosphamide, and adriamycin in advanced ovarian cancer

📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 325 KB

RANDOMISED COMPARISON OF CISPLATIN WITH

RANDOMISED COMPARISON OF CISPLATIN WITH CYCLOPHOSPHAMIDE/CISPLATIN AND WITH CYCLOPHOSPHAMIDE/DOXORUBICIN/ CISPLATIN IN ADVANCED OVARIAN CANCER

✍ Ginecologia, ; Interegionale, Gruppo; Oncologico, Cooperativo 📂 Article 📅 1987 🏛 The Lancet 🌐 English ⚖ 965 KB

High-Intensity Intravenous Cyclophospham

High-Intensity Intravenous Cyclophosphamide and Cisplatin, Interim Surgical Debulking, and Intraperitoneal Cisplatin in Advanced Ovarian Carcinoma: A Pilot Trial with Ten-Year Follow-up

✍ Fred Shapiro; Jeffrey Schneider; Maurie Markman; Bonnie S. Reichman; Ennapadam V 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 87 KB

Treatment of advanced ovarian cancer: A

Treatment of advanced ovarian cancer: A randomised trial comparing adriamycin or 4′epi-adriamycin in combination with cisplatin and cyclophosphamide

✍ Bezwoda, W. R. 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 395 KB

Fifty-one patients with ovarian cancer were tients with < 2 cm residual disease had sigentered in a randomised trial comparing treat-nificantly higher rate of complete remission rnent with cisplatin + adriamycin + cyclo-than those with > 2 crn residual disease. Carphosphamide (PAC) to cisplatin + 4'

Randomised trial comparing combinations

Randomised trial comparing combinations of cyclophosphamide and cisplatin without or with doxorubicin or 4′-epi-doxorubicin in the treatment of advanced ovarian cancer

✍ Z. Hernádi; B. Juhász; R. Póka; L.G. Lampé 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 563 KB

Lack of impact of platinum dose intensit

Lack of impact of platinum dose intensity on the outcome of ovarian cancer patients: 10-year results of a prospective randomised phase III study comparing carboplatin–cisplatin with cyclophosphamide–cisplatin

✍ Ch Dittrich; P Sevelda; H Salzer; A Obermair; P Speiser; G Breitenecker; M Schem 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 412 KB